1. retroroseclothin
2. Straightshooter
1.Straightshooter 01/25/2018
Wedbush reiterates Outperform rating; PT raised to $59 from $52
2.retroroseclothin 01/31/2018
Oppenheimer raises to outperform
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW